your posts are irrelevant as you have no clear delineation between market dynamics and business opportunity in the pharma sector...you demonstrate this repeatedly
correlate the market movements with company valuations across the previous 3 year timelines and the picture is crystal clear .....nothing to do with your inane postulations that really contain very little content related insight.
moguns nailed you down perfectly and you cannot respond effectively
the market has no bottom and no top .....that should be clear
pharma R&D is not simply an exercise in marketing ......as you contest
you should not be investing in pharma R&D stock on startups - you have no concept twhere the value will be realised or how that will occur.
something to consider but i expect some trite crap in response....a clown is a clown is a clown.
- Forums
- ASX - By Stock
- General discussion
your posts are irrelevant as you have no clear delineation...
-
-
- There are more pages in this discussion • 259 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online